查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888810

獸用眼科藥品市場規模、佔有率和趨勢分析報告：按動物、藥物、適應症、通路、地區和細分市場預測（2025-2033 年）

Veterinary Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Animal, By Drug, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸用眼科藥品市場摘要

2024年全球獸用眼​​科藥品市場規模估計為19.5億美元，預計2033年將達36億美元。

預計從 2025 年到 2033 年，該市場將以 7.00% 的複合年成長率成長。推動市場成長的因素包括眼科藥物傳輸技術的進步、長效眼科治療方法的不斷開發、對抗生素管理和循證用藥的日益重視，以及對複雜眼科疾病治療日益成長的臨床需求。

藥物輸送技術的進步正在推動市場成長。耶路撒冷希伯來大學於2025年4月進行的一項研究發現，使用交聯玻尿酸（XHA）的眼藥水比傳統配方效果更佳。具體而言，與使用聚乙烯醇基眼藥水的犬隻相比，使用XHA基眼藥水的犬隻眼內Cefazolin暴露量高出2.4倍，氯黴素暴露量高出4.2倍。這項改進意義重大，因為更高的藥物濃度和更長的眼表停留時間意味著更少的給藥次數和更高的寵物飼主依從性。給藥負擔的減輕提高了高價值眼科藥物在獸醫領域的吸引力。

此外，2025年4月發表在drug.com網站上的一篇報導進一步支持了這一發現，文章解釋說，透明質酸載體可以延長抗生素在犬眼中的持續時間，從而降低抗生素抗藥性的風險。值得注意的是，透明質酸本身俱有抗菌特性，並能促進眼部組織的癒合。因此，動物醫藥生產商看到了開發將抗生素與XHA等先進載體技術結合的眼科製劑的潛力。這些製劑有望提高眼部感染疾病的治療效果，同時為開發具有類似遞送增強效果的新型藥物（例如抗真菌藥物、免疫調節劑和抗青光眼藥物）鋪路。

總之，能夠提高藥物暴露量、減少給藥頻率並提升療效的技術正在推動獸用眼科藥物的需求成長。獸醫診所更傾向於選擇療效較佳、對飼主刺激性較小的製劑。製造商也透過創新給藥系統來應對這一需求，從而推動獸用眼科市場實現更強勁的成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章：獸用眼科藥品市場趨勢及範圍

  • 市場體系展望
    • 母市場
    • 相關市場
  • 市場動態
  • 獸用眼科藥品市場分析工具
    • 波特五力分析
    • PESTEL分析（基於SWOT分析）
    • 按地區和主要物種分類的動物數量估計（2024 年）

第4章 獸用眼科藥品市場：依動物種類分類，市場規模估算及趨勢分析

  • 獸用眼科藥品市場：依動物類型分析變化
  • 獸用眼科藥品市場規模及依物種分類的趨勢（2021-2033 年）
  • 狗
  • 貓
  • 馬
  • 牛
  • 其他動物

第5章 獸用眼科藥品市場：藥物細分、預測及趨勢分析

  • 獸用眼科藥品市場：依藥物分析市場波動
  • 獸用眼科藥品市場規模及趨勢分析（依藥品分類，2021-2033 年）
  • 抗生素
  • 非類固醇消炎劑（NSAIDs）
  • 皮質類固醇
  • 潤滑劑/人工淚液
  • 止痛藥/止痛劑
  • 其他藥物

第6章 獸用眼科藥品市場：依適應症分類的估算與趨勢分析

  • 獸用眼科藥品市場：依適應症分析變化
  • 獸用眼科藥品市場規模及趨勢分析（依適應症分類，2021-2033 年）
    • 眼瞼異常
    • 白內障
    • 青光眼
    • 葡萄膜炎
    • 結膜炎
    • 角膜併發症
    • 其他跡象

第7章 獸用眼科藥品市場：依通路分類的估算與趨勢分析

  • 獸用眼科藥品市場：通路變化分析
  • 獸用眼科藥品市場規模及趨勢分析（依通路分類）（2021-2033 年）
    • 獸醫醫院和診所
    • 專賣店
    • 電子商務
    • 其他分銷管道

第8章 獸用眼科藥品市場：區域、預測與趨勢分析

  • 區域儀錶板
  • 按地區分類的獸用眼科藥品市場佔有率（2024 年和 2033 年）
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 市場參與企業分類
  • 公司市場分析/熱力圖分析
  • 公司簡介
    • Merck &Co., Inc.
    • Zoetis
    • Dechra Pharmaceuticals
    • Virbac
    • Ceva Sante Animale
    • Elanco
    • Bausch &Lomb
    • Sandoz
    • Norbrook Laboratories
    • I-Med Animal Health
Product Code: GVR-4-68040-826-4

Veterinary Ophthalmic Drugs Market Summary

The global veterinary ophthalmic drugs market size was estimated at USD 1.95 billion in 2024 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 7.00% from 2025 to 2033. Some of the factors driving the market growth are advancements in ophthalmic drug-delivery technologies, rising development of long-acting ophthalmic therapies, increasing focus on antimicrobial stewardship & evidence-based use, and growing clinical demand for treatment of complex ocular diseases.

Advances in drug-delivery technology are driving market growth. An April 2025 study at the Hebrew University of Jerusalem found that eyedrops using cross-linked hyaluronic acid (XHA) achieved better results than traditional formulations. Specifically, dogs treated with XHA-based drops had 2.4 times greater exposure to cefazolin and 4.2 times greater exposure to chloramphenicol compared to drops using polyvinyl alcohol. This improvement matters because higher drug concentration and longer retention on the ocular surface mean fewer doses and better compliance among pet owners. Lower dosing burden increases the appeal of premium ophthalmic drugs in veterinary practice.

Moreover, another April 2025 drugs.com article confirmed this finding, explaining that the hyaluronic acid carrier allowed antibiotics to stay longer on canine eyes and suggested a reduced risk of antibiotic resistance. It is noted that hyaluronic acid itself has antiseptic properties and supports the healing of eye tissues. As a result, veterinary pharmaceutical firms see an opportunity in developing ophthalmic formulations that combine antibiotics with advanced carriers like XHA. These deliver better outcomes for eye infections and open the door for new categories, such as anti-fungal, immunomodulators, and anti-glaucoma agents with similar delivery enhancements.

To conclude, technology that boosts drug exposure, reduces frequency of dosing, and improves therapeutic effect is pushing demand for veterinary eye-care drugs. Veterinary clinics prefer formulations that work better and require less owner effort. Manufacturers respond by innovating delivery systems. The net effect is stronger growth in the veterinary ophthalmology market.

Global Veterinary Ophthalmic Drugs Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary ophthalmic drugs market report based on animal, drug, indication, distribution channel, and region:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Bovine
  • Others
  • Drug Outlook (Revenue, USD Million, 2021 - 2033)
  • Antibiotics
  • NSAIDs
  • Corticosteroids
  • Lubricants/Artificial Tears
  • Analgesics/Pain Relievers
  • Others Drugs
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Eyelid Abnormalities
  • Cataract
  • Glaucoma
  • Retinal Complications
  • Uveitis
  • Conjunctivitis
  • Corneal Complications
  • Other Indications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Specialty Stores
  • E-Commerce
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Ophthalmic Drugs Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in Ophthalmic Drug-Delivery Technologies
      • 3.2.1.2. Rising Development of Long-Acting Ophthalmic Therapies
      • 3.2.1.3. Increasing Focus on Antimicrobial Stewardship & Evidence-Based Use
      • 3.2.1.4. Growing Clinical Demand for Treatment of Complex Ocular Diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Restrictions on Antibiotic Use in Animals
      • 3.2.2.2. Limited Standardized Guidelines for Ophthalmic Antibiotic Prescribing
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Ophthalmic Drugs Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis, by SWOT
    • 3.3.3. Estimated Animal Population by region, key species, 2024

Chapter 4. Veterinary Ophthalmic Drugs Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Ophthalmic Drugs Market: Animal Movement Analysis
  • 4.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Bovine
    • 4.7.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Animals
    • 4.8.1. Other Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Ophthalmic Drugs Market: Drug Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Ophthalmic Drugs Market: Drug Movement Analysis
  • 5.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Drug, 2021 to 2033 (USD Million)
  • 5.4. Antibiotics
    • 5.4.1. Antibiotics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. NSAIDs
    • 5.5.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Corticosteroids
    • 5.6.1. Corticosteroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Lubricants/Artificial Tears
    • 5.7.1. Lubricants/Artificial Tears Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Analgesics/Pain Relievers
    • 5.8.1. Analgesics/Pain Relievers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others Drugs
    • 5.9.1. Other Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Ophthalmic Drugs Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Ophthalmic Drugs Market: By Indication Movement Analysis
  • 6.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
    • 6.3.1. Eyelid Abnormalities
      • 6.3.1.1. Eyelid Abnormalities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Cataract
      • 6.3.2.1. Cataract Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Glaucoma
      • 6.3.3.1. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Retinal Complications
      • 6.3.3.3. Retinal Complications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Uveitis
      • 6.3.4.1. Uveitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Conjunctivitis
      • 6.3.5.1. Conjunctivitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Corneal Complications
      • 6.3.6.1. Corneal Complications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Other Indications
      • 6.3.7.1. Other Indications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Ophthalmic Drugs Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Ophthalmic Drugs Market: By Distribution Channel Movement Analysis
  • 7.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Specialty Stores
      • 7.3.2.1. Specialty Stores Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. E-Commerce
      • 7.3.3.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Other Distribution Channels
      • 7.3.4.1. Other Distribution Channels Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Ophthalmic Drugs Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Ophthalmic Drugs Market Share, By Region, 2024 & 2033, USD Million
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Qatar
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory Framework
      • 8.8.6.4. Qatar Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Oman
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Competitive Scenario
      • 8.8.7.3. Regulatory Framework
      • 8.8.7.4. Oman Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Merck & Co., Inc.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Dechra Pharmaceuticals
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Virbac
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Ceva Sante Animale
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Elanco
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Bausch & Lomb
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Sandoz
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Norbrook Laboratories
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. I-Med Animal Health
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Ophthalmic Drugs Market, by region, 2021 - 2033 (USD Million)
  • Table 3 Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 4 Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 5 Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 6 Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 Germany Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 30 Germany Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 31 Germany Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 32 Germany Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 33 UK Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 34 UK Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 35 UK Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 36 UK Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 66 China Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 67 China Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 68 China Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 69 China Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Japan Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 71 Japan Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 72 Japan Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 73 Japan Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 78 South Korea Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 79 South Korea Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 80 South Korea Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 81 South Korea Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 82 Australia Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 83 Australia Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 84 Australia Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 85 Australia Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 Thailand Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 87 Thailand Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 88 Thailand Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 89 Thailand Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 103 MEA Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 104 MEA Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 105 MEA Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 106 MEA Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 107 MEA Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 116 UAE Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 117 UAE Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 118 UAE Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 119 UAE Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 132 Company Overview
  • Table 133 Product Benchmarking
  • Table 134 Financial Performance
  • Table 135 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Ophthalmic Drugs Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Veterinary Ophthalmic Drugs Market snapshot
  • Fig. 11 Veterinary Ophthalmic Drugs Market driver impact
  • Fig. 12 Veterinary Ophthalmic Drugs Market restraint impact
  • Fig. 13 Veterinary Eye Care animal key takeaways (USD Million)
  • Fig. 14 Veterinary Ophthalmic Drugs Market: animal, market share 2024 & 2033
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Bovine market, 2021 - 2033 (USD Million)
  • Fig. 19 Other Animals market, 2021 - 2033 (USD Million)
  • Fig. 20 Veterinary Ophthalmic Drugs Market Drug key takeaways (USD Million)
  • Fig. 21 Veterinary Ophthalmic Drugs Market: Drug, market share 2024 & 2033
  • Fig. 22 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 23 NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 24 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 25 Lubricants/Artificial Tears market, 2021 - 2033 (USD Million)
  • Fig. 26 Analgesics/Pain Relievers market, 2021 - 2033 (USD Million)
  • Fig. 27 Other Drugs market, 2021 - 2033 (USD Million)
  • Fig. 28 Veterinary Ophthalmic Drugs Market, by Indication: Key takeaways
  • Fig. 29 Veterinary Ophthalmic Drugs Market, by Indication, market share, 2024 & 2033
  • Fig. 30 Eyelid Abnormalities market, 2021 - 2033 (USD Million)
  • Fig. 31 Cataract market, 2021 - 2033 (USD Million)
  • Fig. 32 Glaucoma market, 2021 - 2033 (USD Million)
  • Fig. 33 Retinal Complications market, 2021 - 2033 (USD Million)
  • Fig. 34 Uveitis market, 2021 - 2033 (USD Million)
  • Fig. 35 Conjunctivitis market, 2021 - 2033 (USD Million)
  • Fig. 36 Corneal Complications market, 2021 - 2033 (USD Million)
  • Fig. 37 Other Indications market, 2021 - 2033 (USD Million)
  • Fig. 38 Veterinary Ophthalmic Drugs Market, by Distribution Channel: Key takeaways
  • Fig. 39 Veterinary Ophthalmic Drugs Market, by Distribution Channel, market share, 2024 & 2033
  • Fig. 40 Veterinary Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 41 Specialty Stores market, 2021 - 2033 (USD Million)
  • Fig. 42 E-Commerce market, 2021 - 2033 (USD Million)
  • Fig. 43 Other Distribution Channels market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 Regional outlook, 2024 & 2033
  • Fig. 46 North America Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 47 U.S. Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 48 Canada Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 49 Mexico Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 51 UK Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 52 Germany Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 53 France Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 54 Italy Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 55 Spain Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 58 Norway Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 59 Asia Pacific Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 60 Japan Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 61 China Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 62 India Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 63 Australia Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 68 Argentina Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 69 MEA Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 71 Saudi Arabia Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 72 UAE Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 73 Kuwait Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 74 Qatar Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 75 Oman Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 76 Market participant categorization